Cargando…
Altered Glucose Homeostasis Is Associated with Increased Serum Apelin Levels in Type 2 Diabetes Mellitus
BACKGROUND: Apelin is an adipokine that plays a role in the regulation of glucose homeostasis and in obesity. The relationship between apelin serum concentration and dysmetabolic conditions such as type 2 diabetes (T2D) is still controversial. Aims of our study are: 1) determine the circulating leve...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515542/ https://www.ncbi.nlm.nih.gov/pubmed/23227256 http://dx.doi.org/10.1371/journal.pone.0051236 |
_version_ | 1782252204215762944 |
---|---|
author | Cavallo, Maria Gisella Sentinelli, Federica Barchetta, Ilaria Costantino, Carmine Incani, Michela Perra, Laura Capoccia, Danila Romeo, Stefano Cossu, Efisio Leonetti, Frida Agati, Luciano Baroni, Marco G. |
author_facet | Cavallo, Maria Gisella Sentinelli, Federica Barchetta, Ilaria Costantino, Carmine Incani, Michela Perra, Laura Capoccia, Danila Romeo, Stefano Cossu, Efisio Leonetti, Frida Agati, Luciano Baroni, Marco G. |
author_sort | Cavallo, Maria Gisella |
collection | PubMed |
description | BACKGROUND: Apelin is an adipokine that plays a role in the regulation of glucose homeostasis and in obesity. The relationship between apelin serum concentration and dysmetabolic conditions such as type 2 diabetes (T2D) is still controversial. Aims of our study are: 1) determine the circulating levels of apelin in a large cohort of Italian subjects with T2D, T1D and in non-diabetic controls; 2) identify putative metabolic determinants of modified apelin concentrations, in order to search possible mechanism of apelin control; 3) investigate changes in apelin levels in response to sharp modifications of glucose/insulin metabolism in T2D obese subjects before and 3 days after bariatric surgery. METHODS: We recruited 369 subjects, 119 with T2D, 113 with T1D and 137 non-diabetic controls. All subjects underwent a complete clinical examination, including anthropometric and laboratory measurements. Serum apelin levels were determined by EIA (immunoenzyme assay). RESULTS: Patients with T2D had significantly higher serum apelin levels compared to controls (1.23±1.1 ng/mL vs 0.91±0.7 ng/mL, P<0.001) and to T1D subjects (0.73±0.39 ng/mL, P<0.001). Controls and T1D subjects did not differ significantly in apelin levels. Apelin concentrations were directly associated with fasting blood glucose (FBG), body mass index (BMI), basal Disposition Index (DI-0), age, and diagnosis of T2D at bivariate correlation analysis. Multiple regression analysis confirmed that diagnosis of T2D, basal DI-0 and FBG were all determinants of serum apelin levels independently from age and BMI. Bariatric surgery performed in a subgroup of obese diabetic subjects (n = 12) resulted in a significant reduction of apelin concentrations compared to baseline levels (P = 0.01). CONCLUSIONS: Our study demonstrates that T2D, but not T1D, is associated with increased serum apelin levels compared to non-diabetic subjects. This association is dependent on impaired glucose homeostasis, and disappears after bariatric surgery, providing further evidence regarding the relationship between apelin and the regulation of glucose metabolism. |
format | Online Article Text |
id | pubmed-3515542 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35155422012-12-07 Altered Glucose Homeostasis Is Associated with Increased Serum Apelin Levels in Type 2 Diabetes Mellitus Cavallo, Maria Gisella Sentinelli, Federica Barchetta, Ilaria Costantino, Carmine Incani, Michela Perra, Laura Capoccia, Danila Romeo, Stefano Cossu, Efisio Leonetti, Frida Agati, Luciano Baroni, Marco G. PLoS One Research Article BACKGROUND: Apelin is an adipokine that plays a role in the regulation of glucose homeostasis and in obesity. The relationship between apelin serum concentration and dysmetabolic conditions such as type 2 diabetes (T2D) is still controversial. Aims of our study are: 1) determine the circulating levels of apelin in a large cohort of Italian subjects with T2D, T1D and in non-diabetic controls; 2) identify putative metabolic determinants of modified apelin concentrations, in order to search possible mechanism of apelin control; 3) investigate changes in apelin levels in response to sharp modifications of glucose/insulin metabolism in T2D obese subjects before and 3 days after bariatric surgery. METHODS: We recruited 369 subjects, 119 with T2D, 113 with T1D and 137 non-diabetic controls. All subjects underwent a complete clinical examination, including anthropometric and laboratory measurements. Serum apelin levels were determined by EIA (immunoenzyme assay). RESULTS: Patients with T2D had significantly higher serum apelin levels compared to controls (1.23±1.1 ng/mL vs 0.91±0.7 ng/mL, P<0.001) and to T1D subjects (0.73±0.39 ng/mL, P<0.001). Controls and T1D subjects did not differ significantly in apelin levels. Apelin concentrations were directly associated with fasting blood glucose (FBG), body mass index (BMI), basal Disposition Index (DI-0), age, and diagnosis of T2D at bivariate correlation analysis. Multiple regression analysis confirmed that diagnosis of T2D, basal DI-0 and FBG were all determinants of serum apelin levels independently from age and BMI. Bariatric surgery performed in a subgroup of obese diabetic subjects (n = 12) resulted in a significant reduction of apelin concentrations compared to baseline levels (P = 0.01). CONCLUSIONS: Our study demonstrates that T2D, but not T1D, is associated with increased serum apelin levels compared to non-diabetic subjects. This association is dependent on impaired glucose homeostasis, and disappears after bariatric surgery, providing further evidence regarding the relationship between apelin and the regulation of glucose metabolism. Public Library of Science 2012-12-05 /pmc/articles/PMC3515542/ /pubmed/23227256 http://dx.doi.org/10.1371/journal.pone.0051236 Text en © 2012 Cavallo et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Cavallo, Maria Gisella Sentinelli, Federica Barchetta, Ilaria Costantino, Carmine Incani, Michela Perra, Laura Capoccia, Danila Romeo, Stefano Cossu, Efisio Leonetti, Frida Agati, Luciano Baroni, Marco G. Altered Glucose Homeostasis Is Associated with Increased Serum Apelin Levels in Type 2 Diabetes Mellitus |
title | Altered Glucose Homeostasis Is Associated with Increased Serum Apelin Levels in Type 2 Diabetes Mellitus |
title_full | Altered Glucose Homeostasis Is Associated with Increased Serum Apelin Levels in Type 2 Diabetes Mellitus |
title_fullStr | Altered Glucose Homeostasis Is Associated with Increased Serum Apelin Levels in Type 2 Diabetes Mellitus |
title_full_unstemmed | Altered Glucose Homeostasis Is Associated with Increased Serum Apelin Levels in Type 2 Diabetes Mellitus |
title_short | Altered Glucose Homeostasis Is Associated with Increased Serum Apelin Levels in Type 2 Diabetes Mellitus |
title_sort | altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515542/ https://www.ncbi.nlm.nih.gov/pubmed/23227256 http://dx.doi.org/10.1371/journal.pone.0051236 |
work_keys_str_mv | AT cavallomariagisella alteredglucosehomeostasisisassociatedwithincreasedserumapelinlevelsintype2diabetesmellitus AT sentinellifederica alteredglucosehomeostasisisassociatedwithincreasedserumapelinlevelsintype2diabetesmellitus AT barchettailaria alteredglucosehomeostasisisassociatedwithincreasedserumapelinlevelsintype2diabetesmellitus AT costantinocarmine alteredglucosehomeostasisisassociatedwithincreasedserumapelinlevelsintype2diabetesmellitus AT incanimichela alteredglucosehomeostasisisassociatedwithincreasedserumapelinlevelsintype2diabetesmellitus AT perralaura alteredglucosehomeostasisisassociatedwithincreasedserumapelinlevelsintype2diabetesmellitus AT capocciadanila alteredglucosehomeostasisisassociatedwithincreasedserumapelinlevelsintype2diabetesmellitus AT romeostefano alteredglucosehomeostasisisassociatedwithincreasedserumapelinlevelsintype2diabetesmellitus AT cossuefisio alteredglucosehomeostasisisassociatedwithincreasedserumapelinlevelsintype2diabetesmellitus AT leonettifrida alteredglucosehomeostasisisassociatedwithincreasedserumapelinlevelsintype2diabetesmellitus AT agatiluciano alteredglucosehomeostasisisassociatedwithincreasedserumapelinlevelsintype2diabetesmellitus AT baronimarcog alteredglucosehomeostasisisassociatedwithincreasedserumapelinlevelsintype2diabetesmellitus |